Dr.D.G. Saple

Dr.D.G. Saple
Dermatologist, Mumbai

MBBS, MD, FCPS, DDV

  • 1 Private Practice
  • Consultant Dermatologist at La’mer clinic , Center for Dermatology & Cosmetology
  • Consultant in Dermato-venereology, Leprology & HIV/AIDS Breach Candy Hospital & Trust, All India Institute of Diabetes S. L. Raheja Hospital & Fortis Associate, Mumbai
  • HOD Dermato-venereology, Leprology in Bulabhai Nanavati Hospital Mumbai
  • Hon. Director HIV/AIDS Clinical Research Programme, Human Healthcare & Research Foundation, Mumbai
  • Trainer for Fellowship Programme in HIV/AIDS, IADVL
  • Examiner for M.D.(various universities)
  • Pioneer researcher in epidemiology and management of HIV/AIDS in India

Specialities

  • Dermatology (Skin)

Expertise

Education

  • MBBS from Grant Medical College, University of Mumbai
  • DDV from College of Physicians & SurgeonsUniversity of Mumbai
  • FCPS from College of Physicians & SurgeonsUniversity of Mumbai
  • MD from Grant Medical College, Mumbai
  • Fellow of Johns Hopkins University, Bloomberg, USA 

Practice Information

Private Practice Information

La mer Clinic

La mer Clinic

134, Mohan Bagan,Sir Bhalchandra Road, Hindu Colony, Near King George School Circle, Dadar East, Mumbai - 400014 ,

  • (022) 24161122, (022) 24161133

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr.D.G. Saple and his staff know how they are doing and how they can improve their services.

Achievements & Contributions

  • RESEARCH, PUBLICATIONS Editorial Board Member, IADVL Textbook of Dermatology, IJSTD 
  • 22+ peer-reviewed publications in journals (e.g. IJDVL; IJSTD; Clin Infect Dis; AIDS Patient Care STDS; J Clin Microbiol; Journal of HIV therapy; JAPI; International Journal of STDs & AIDS; Journal of Human Virology; Acta Virol) 
  • Chapters in Medical textbooks
  • 35+ papers presented in international conferences
  • RESEARCH INTEREST Clinical Dermatology, Trichology & Cosmetology
  • Dermatopathology
  • Dermatotherapeutics
  • HIV/AIDS
  • Clinical trials in Dermatology, cosmetology & HIV
  • RESEARCH PAPERS PRESENTED AT INTERNATIONAL SCIENTIFIC MEETINGS :Cryptococcal Meningitis in HIV, 1st International Congress on AIDS in Asia and Pacific, New Delhi, India, 1992
  • Inguinal Tuberculous Lymphadenopathy in HIV Infection, 9th International AIDS Conference, Berlin, 1993 
  • Dermatological markers of HIV disease in Bombay, India. 9th International AIDS Conference. 1993
  • Dermatological manifestations in HIV infection in Bombay 7th International Congress of Dermatology, New Delhi, India, 1994
  • Clinical profile of tuberculosis in 14,000 HIV patients 3rd International Conference on AIDS in Asia and the Pacific, Thailand, 1995
  • Multiple drug resistance tuberculosis & mycobacteriosis in HIV infection, 11th International AIDS Conference, Vancouver, 1996
  • Scenario of antiretroviral therapy (ART) in 25,000 HIV/AIDS individuals in Mumbai, India. 12th International AIDS Conference, Geneva, 1998 
  • Compliance of tuberculosis patients in HIV/AIDS Clinic G.T. Hospital, Mumbai, India. 12th International AIDS Conference, Geneva, 1998 
  • Profile Tuberculosis in 3500 HIV/AIDS patients studied during 13 years 5th International Congress on AIDS in Asia and Pacific, Kuala Lumpur 1999
  • Survival rate of Cryptococcal meningitis patient at HIV/AIDS referral centre G.T. Mumbai India 5th International Congress on AIDS in Asia and Pacific Kuala Lumpur 1999
  • Family support of HIV positive patients, 5th International Congress on AIDS in Asia and Pacific Kuala Lumpur 1999
  • Presentation of STDs in 35000 HIV/AIDS patients, 13th meeting of the international society for sexually transmitted diseases research 1999 Denver, Colorado, USA
  • Developing methods for examining the social, behavioural, and economic impact of HIV/AIDS on patients visiting a Hospital-based Std/Aids clinic: the s.b.e pilot study at gokuldas-tejpal hospital in Mumbai (Bombay), India. 13th International AIDS Conference, Durban July 2000 
  • Two Drug ART - Compromised formula in resource limited settings, 13th International AIDS Conference, Durban July 2000
  • Management of cryptococcal meningitis in HIV/AIDS patients in resource limited settings, 13th International AIDS conference Durban 2000.
  • Survival rate of Toxoplasma encephalitis in HIV/AIDS patients 13th International AIDS Conference, Durban July 2000
  • Treatment of opportunistic infections versus antiretroviral therapy in India, 13th International AIDS Conference, Durban July 2000
  • Observational follow Up 100 HIV discordant couples for 4years in India. 14th International AIDS Conference, Barcelona, 2002 
  • Impact of awareness of available treatment in HIV/AIDS patients and Physicians. 14th International AIDS Conference, Barcelona, 2002
  • Prenatal and paediatric HIV - observations and trends of vertical transmission and clinical features. 14th International AIDS Conference, Barcelona, 2002
  • 6-year longitudinal follow-up of 50 HCW exposed to needle stick injury of symptomatic HIV infected patients in India. 14th International AIDS Conference, Barcelona, 2002
  • Home Care Management of HIV/AIDS Patients in INDIA. 14th International AIDS Conference, Barcelona, 2002
  • Impact of Counselling on Management of Tuberculosis in HIV/AIDS Patients in Mumbai, India. 14th International AIDS Conference, Barcelona, 2002
  • Causes of ARV Failure in India. 14th International AIDS Conference, Barcelona, 2002
  • Efficacy and affordability of 2 NRTI & 1 NNRTI in India --an open study. 14th International AIDS Conference, Barcelona, 2002
  • ART in India: Glorious possibilities but uncertain success, 6th International Congress on Drug Therapy in HIV Infection, Glasgow, 2002
  • Generic AZT vs. d4T In HIV/TB Co-infection in Clinical Practice In India: An Observational Study.11th Conference Retroviruses Opportunistic Infection, San Franc CA, 2004
  • TB a key determinant of ART Success in Indian Setting: A Multicentric Study, 7th International Congress on Drug Therapy in HIV Infection, Glasgow, 2004
  • Generic ART associated toxicity in resource restricted setting: 3rd IAS Conference on HIV Pathogenesis and Treatment - 24-27 July 2005 - Rio de Janeiro Brazil
  • Boosted PI to NVP switch in advanced HIV disease - integrating potency, simplification and cost reduction: A pilot study in resource restricted settings: 3rd IAS Conference on HIV Pathogenesis and Treatment - 24-27 July 2005 - Rio de Janeiro Brazil.
  • Comparative efficacy of antiretroviral treatment regimens in resource restricted setting: 3rd IAS Conference on HIV Pathogenesis and Treatment - 24-27 July 2005 - Rio de Janeiro Brazil.
  • Knowledge, attitudes and practices of HIV care and antiretroviral therapy among HIV infected adults attending private and public clinics in India, XVI international AIDS conference 13-18 August 2006. Toronto, Canada. 
  • Use of total lymphocyte count in primary care settings as a monitoring tool for HIV disease progression. XVI international AIDS conference 13-18 August 2006. Toronto, Canada.
  • Adherence to antiretroviral therapy among Indian HIV-infected persons seeking care in private sector in Mumbai, India. XVI international AIDS conference 13-18 August 2006. Toronto, Canada.
  • “Single, dual and triple class resistance among HIV-infected patients on antiretroviral therapy in private care clinics: Mumbai, India”. AIDS Res Hum Retroviruses. 2010 Jan; 26(1):25-31. Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Human Healthcare and Research Foundation, Mumbai, India University of North Carolina, Raleigh, North Carolina, USA National AIDS Research Institute, Pune, India
  • “Physician Estimate of Antiretroviral Adherence in India: Poor Correlation with Patient Self-Report and Viral Load”. AIDS Patient Care STDS. 2010 Mar; 24(3):189-95.Bloomberg School of Public Health, 4School of Medicine, Johns Hopkins University, Baltimore, Maryland. Human Healthcare and Research Foundation, Mumbai, India. Department of Emergency Medicine, School of Medicine, Emory University, Atlanta, Georgia
  • “Safety and Efficacy Profiles of Elvucitabine in Naïve HIV-1 Infected Patients” : 17th International AIDS Conference, Mexico City, August 2008.
  • “Generic ART associated toxicity in resource restricted setting”: 3rd IAS Conference on HIV Pathogenesis and Treatment - 24-27 July 2005 - Rio de Janeiro Brazil
  • Lymphoma In HIV Patients: Varied Presentations (Indian Journal of Medical and Paediatric Oncology – Jan-Mar 2010 – Vol 31 – Issue 1) 
  • SELECTED TEXT- BOOK PUBLICATIONS :Chapter entitled "AIDS" in "Textbook & Atlas of Dermatology" published by Indian Association of Dermatologist, Venereologist & Leprologists, Volume I.
  • Chapter entitled "Principles of Antiretroviral Therapy" in Textbook & Atlas of Dermatology published by Indian Association of Dermatologist, Venereologist & Leprologists, Volume I
  • Current practices of ART in India - Mumbai "The Association of Phycsians of India" Medicine Update Volume 13. 2003
  • PEER REVIEWED PUBLICATIONSAnderson-Fabry's disease with marfanoid features. Indian J Dermatol Venereol Leprol. 2008;74:389-91.Surjushe A, Jindal S, Sao P, Medhekar S, Saple DG. 
  • Darier's sign. Indian J Dermatol Venereol Leprol 2007 Sep-Oct; 73(5):363-4.
  • A clinical and mycological study of onychomycosis in HIV infection. Indian J Dermatol Venereol Leprol 2007 Nov-Dec; 73(6):397-401. 
  • Hand-foot syndrome due to capecitabine. Surjushe A, Vasani R, Medhekar S, Thakre M, Saple DG. Indian J Dermatol. 2009 Jul;54(3):301-2.
  • Tumoral calcinosis. Jindal S, Surjushe A, Sao P, Saple DG. Indian J Dermatol Venereol Leprol. 2008 May-Jun;74(3):282-3
  • Evaluation of the efficacy, safety and tolerability of Tacrolimus ointment in Indian patients of moderate to severe atopic dermatitis: a multicentric, open label, phase III study. Indian J Dermatol Venereol Leprol. 2003 Nov-Dec; 69(6):396-400.
  • Efficacy and safety of butenafine in superficial dermatophytoses (tinea pedis, tinea cruris, tinea corporis). J Indian Med Assoc. 2001 May; 99(5):274-5. 
  • An open study to evaluate the efficacy and safety of tazarotene gel (0.1%) in acne vulgaris. Indian J Dermatol Venereol Leprol. 2004 Mar-Apr; 70(2):92-5.
  • Evaluation of safety and efficacy of ketoconazole 2% and zinc pyrithione 1% shampoo in patients with moderate to severe dandruff--a postmarketing study. J Indian Med Assoc. 2000 Dec; 98(12):810-1
  • Efficacy and tolerability of sertaconazole nitrate 2% cream vs. miconazole in patients with cutaneous dermatophytosis. Sharma A, Saple DG, Surjushe A, Rao GR, Kura M, Ghosh S, Bolmall C, Baliga V. Mycoses. 2011 May;54(3):217-22.
  • Pictorial CME. AIDS-related cryptococcus infection presenting with molluscum contagiosum-like skin lesions. J Assoc Physicians India 1998 Apr; 46(4):368. 
  • Efficacy and tolerability of sertaconazole nitrate 2% cream vs. miconazole in patients with cutaneous dermatophytosis. Sharma A, Saple DG, Surjushe A, Rao GR, Kura M, Ghosh S, Bolmall C, Baliga V. Mycoses. 2011 May;54(3):217-22
  • Interleukin-9 receptor alpha chain mRNA formation in CD8+ T cells producing anti-human immunodeficiency virus type 1 substance(s). Acta Virol. 1998 Feb; 42(1):47-53. 
  • Pictorial CME. Histoplasmosis in HIV seropositivity. J Assoc Physicians India 1998 Mar; 46(3):281. 
  • Mycophenolate mofetil. Surjushe A, Saple DG. Indian J Dermatol Venereol Leprol. 2008 Mar-Apr;74(2):180-4. Review
  • Aloe vera: a short review. Surjushe A, Vasani R, Saple DG. Indian J Dermatol. 2008;53(4):163-6. /> 17. Cryptosporidium, isospora and strongyloides in AIDS. Natl Med J India 1996 Jan-Feb; 9(1):17-9. 
  • STDs AND AIDS. Indian journal sexually transmitted disease. 1999, 20: 1:37-39.
  • Seronegative HIV-2 carries in India ,International Journal of STDs & AIDS, 2000
  • Increased promoter Diversity Reveals a complex Phylogeny of Human Immunodeficiency Virus Type 1 Subtype C in India. Journal of Human Virology, January/ February 2000
  • Cyclospora infection in acquired immunodeficiency syndrome. J Assoc Physicians India 2000 Apr; 48(4):404-6. 
  • Difficulties encountered with the use of antiretroviral drugs in India. J HIV Ther 2002 Aug; 7(3):56-8. 
  • Introduction of human immunodeficiency virus type 2 infection in the Philippines.J Clin Microbiol 2003 Jan; 41(1):516-8. 
  • Improving adherence to antiretroviral therapy. Indian J Dermatol Venereol Leprol. 2005 Sep-Oct; 71(5):316-20. Review
  • Immune reconstitution inflammatory syndrome. Indian J Dermatol Venereol Leprol. 2006 Nov-Dec; 72(6):410-4.
  • Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India. Clin Infect Dis. 2007 May 1; 44(9):1235-44. Epub 2007 Mar 22.
  • Knowledge, attitudes, and practices of antiretroviral therapy among HIV-infected adults attending private and public clinics in India.`AIDS Patient Care STDS, 2007 Feb; 21(2):129-42. 
  • Lymphoma in HIV patients: Varied presentations. Saple DG, Shah I, Surjushe AU, Murthy A, Chudgar P, Gote PD. Indian J Med Paediatr Oncol. 2010 Jan;31(1):39-42.
  • Physician estimate of antiretroviral adherence in India: poor correlation with patient self-report and viral load. Walshe L, Saple DG, Mehta SH, Shah B, Bollinger RC, Gupta A. AIDS Patient Care STDS. 2010 Mar;24(3):189-95.
  • One-, two-, and three-class resistance among HIV-infected patients on antiretroviral therapy in private care clinics: Mumbai, India. Gupta A, Saple DG, Nadkarni G, Shah B, Vaidya S, Hingankar N, Chaturbhuj D, Deshmukh P, Walshe L, Hudelson SE, James M, Paranjape RS, Eshleman SH, Tripathy S.
  • HIV-2 amino acid substitutions in Gag and Env proteins occurring simultaneously with viral load upsurge in a drug-naïve patient. Kageyama S, Maniar JK, Saple DG, Numazaki K, Kurimura T, Ichimura H. J Infect Chemother. 2008 Apr;14(2):151-5. Epub 2008 Apr 30.
  • Early antiretroviral therapy: the pendulum shifts again. Saple DG, Jindal S, Vaidya S. Indian J Dermatol Venereol Leprol. 2008 May-Jun;74(3):189-92
  • Clinical evaluation of ointment containing mupirocin and betamethasone in infected dermatoses. Saple DG, Desai A. Indian J Dermatol Venereol Leprol. 2000 Jul-Aug;66(4):196-9
  • 22nd National Conference of the Indian Association for the Study of Sexually Transmitted Diseases and AIDS (IASSTD) 6-8 March 1998, Mumbai, India. Maniar JK, Saple DG, Bingham JS. Int J STD AIDS. 1998 Oct;9(10):620-1